SCHEMBL11528134

SCHEMBL11528134

O=C(N1CCc2cc(O)c(O)cc2C(c2ccccc2)C1)C(F)(F)F

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 12/20 0.64
▸ HSD17B10 Q99714 5/20 0.64
▸ THPO P40225 3/20 0.64
▸ HIF1A Q16665 2/20 0.64
▸ MTOR P42345 2/20 0.64
▸ MAPK1 P28482 1/20 0.64
▸ DRD2 P14416 4/20 0.62
▸ KDM4E B2RXH2 3/20 0.62
▸ MAPT P10636 2/20 0.62
▸ BLM P54132 2/20 0.62
▸ PMP22 Q01453 2/20 0.62
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ CYP2D6 P10635 4/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ DRD5 P21918 3/20 0.53
▸ CYP1A2 P05177 3/20 0.53
▸ TSHR P16473 3/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11529303 0.84 ESR1 (0.45) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL11454330 0.82 ESR1 (0.54) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL10746034 0.82 CYP3A4 (0.56) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL11529300 0.82 ESR1 (0.43) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL11270417 0.81 DRD1 (0.50) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL17040358 0.81 DRD1 (0.64) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL10748766 0.81 CYP2D6 (0.55) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL10746175 0.79 CYP3A4 (0.53) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL17037453 0.79 DRD1 (0.61) DRD1HSD17B10THPOHIF1AMTOR
SCHEMBL11478094 0.79 DRD1 (0.53) DRD1HSD17B10THPOHIF1AMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4172890-A CARDIOVASCULAR, PARKINSON'S DISEASE, DOPAMINERGIC SMITHKLINE CORPORATION (US) 1979-10-30 — — US disclosed
US-4171359-A DOPAMINERGIC ACTIVITY SMITHKLINE CORPORATION (US) 1979-10-16 — — US disclosed
US-4165372-A 6-Carboxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds and use as dopaminergic agents SMITHKLINE CORPORATION (US) 1979-08-21 — — US disclosed
US-4160765-A Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds SMITHKLINE CORPORATION (US) 1979-07-10 — — US disclosed
US-4108989-A TREATING PARKINSON*S DISEASE, CARDIOVASCULAR DISORDERS SMITHKLINE CORPORATION (US) 1978-08-22 — — US disclosed
Send feedback